Search Results 181-190 of 16894 for monoclonal antibody

1. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

2. Focus Areas - T Cell Engineering Laboratory - Mayo Clinic Research

   These include secondary modification of CAR-T cells and combination strategies with monoclonal antibodies, small molecules, peptides and other immunotherapeutic ...

3. Ravulizumab-cwvz (intravenous route) - Side effects & uses - Mayo Clinic

   Ravulizumab-cwvz injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...

4. Pediatric Brain Tumor Surgery Clinical Trials - Mayo Clinic Research

   Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

5. Clinical trials - Oncology (Medical)

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

6. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody that does inhibit CD38 activity (Deckert et al., 2014).For this first-in-human study, relapsed/refractory multiple myeloma has been ...

7. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

   Monoclonal antibodies, such as ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-CTLA4 monoclonal antibody).

8. Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

   A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

9. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal ...

10. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...